Literature DB >> 16186233

Interferon resistance of hepatitis C virus replicon-harbouring cells is caused by functional disruption of type I interferon receptors.

Kazuhito Naka1, Kazunori Takemoto1, Ken-Ichi Abe1, Hiromichi Dansako1, Masanori Ikeda1, Kunitada Shimotohno2, Nobuyuki Kato1.   

Abstract

Hepatitis C virus (HCV) replicon-harbouring cell lines possessing interferon (IFN)-resistant phenotypes have recently been established. These were divided into two classes: partially IFN resistant and highly IFN resistant. Here, the viral and cellular factors contributing to the IFN resistance of HCV replicon-harbouring cells were evaluated. The results revealed that cellular factors rather than viral factors contributed to a highly IFN-resistant phenotype. The possibility of genetic abnormality of the factors involved in IFN signalling was investigated. As a result, nonsense mutations and deletions in type I IFN receptor genes (IFNAR1 and IFNAR2c) were found in replicon-harbouring cells showing a highly IFN-resistant phenotype, but rarely appeared in cells showing a partially IFN-resistant phenotype. Furthermore, similar genetic alterations were also found in IFN-resistant phenotype, replicon-harbouring cell lines obtained additionally by IFN-beta treatment. Moreover, it was shown that ectopic expression of wild-type IFNAR1 in IFN-resistant phenotype, replicon-harbouring cells possessing the IFNAR1 mutant restored type I IFN signalling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186233     DOI: 10.1099/vir.0.81124-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  "Self" and "nonself" manipulation of interferon defense during persistent infection: bovine viral diarrhea virus resists alpha/beta interferon without blocking antiviral activity against unrelated viruses replicating in its host cells.

Authors:  Matthias Schweizer; Philippe Mätzener; Gabriela Pfaffen; Hanspeter Stalder; Ernst Peterhans
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Multifaceted activities of type I interferon are revealed by a receptor antagonist.

Authors:  Doron Levin; William M Schneider; Hans-Heinrich Hoffmann; Ganit Yarden; Alberto Giovanni Busetto; Ohad Manor; Nanaocha Sharma; Charles M Rice; Gideon Schreiber
Journal:  Sci Signal       Date:  2014-05-27       Impact factor: 8.192

3.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

4.  Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.

Authors:  Sidhartha Hazari; Partha K Chandra; Bret Poat; Sibnarayan Datta; Robert F Garry; Timothy P Foster; Gus Kousoulas; Takaji Wakita; Srikanta Dash
Journal:  Virol J       Date:  2010-02-11       Impact factor: 4.099

5.  Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.

Authors:  Dong Jiang; Haitao Guo; Chunxiao Xu; Jinhong Chang; Baohua Gu; Lijuan Wang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

6.  Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.

Authors:  Xiaoyu Wen; Takayuki Abe; Hiroshi Kukihara; Shuhei Taguwa; Yoshio Mori; Hideki Tani; Nobuyuki Kato; Tetsuro Suzuki; Masashi Tatsumi; Kohji Moriishi; Yoshiharu Matsuura
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

7.  Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.

Authors:  Sibnarayan Datta; Sidhartha Hazari; Partha K Chandra; Maria Samara; Bret Poat; Feyza Gunduz; William C Wimley; Hansjorg Hauser; Mario Koster; Christophe Lamaze; Luis A Balart; Robert F Garry; Srikanta Dash
Journal:  Virol J       Date:  2011-07-14       Impact factor: 4.099

8.  Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.

Authors:  John M Robida; Heather B Nelson; Zhe Liu; Hengli Tang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

9.  Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.

Authors:  Sidhartha Hazari; Lizeth Taylor; Salima Haque; Robert F Garry; Sander Florman; Ronald Luftig; Frederic Regenstein; Srikanta Dash
Journal:  Virol J       Date:  2007-09-18       Impact factor: 4.099

Review 10.  Modulation of host metabolism as a target of new antivirals.

Authors:  Masanori Ikeda; Nobuyuki Kato
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.